1. ACT-13 DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY. (3rd December 2022) Authors: Yoshiki, Arakawa; Reardon, David; Narita, Yoshitaka; Goldlust, Samuel; Anstass, George; McMullen, Dragana; Dow, Edward; Seki, Masataka; Furuta, Yudai; Song, Gregory; Colman, Howard Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 3 Page Start: iii8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RTID-03. DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA: A FIRST-IN-HUMAN, PHASE 1 STUDY. (14th November 2022) Authors: Reardon, David A; Narita, Yoshitaka; Arakawa, Yoshiki; Goldlust, Samuel; Anstass, George; McMullen, Dragana; Dow, Edward; Seki, Masataka; Furuta, Yudai; Song, Gregory; Colman, Howard Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗